Ever Supreme has advanced research and developing capability in cell gene manufacturing processes of both stem cells and immune cells drugs.

Ever Supreme has advanced cell process developments and manufacturing technologies on two types of emerging drugs: stem cells and immune cells, which are applied to the development of new indications, the manufacture of cell products, and other services.

We have obtained the exclusive licensing on stem cell culturing system to establish a complete stem cell culturing processes, optimization processes, and an analytical platform.  Currently, a number of new mesenchymal stem cell drugs are being developed for cardiovascular diseases and brain damages.

We have an exclusive licensing for the preparation of immune cell tumor vaccines, in which the autologous immune cell tumor vaccines was used to increase tumor-specific T-cells, and jointly combined personalized medicine and precision medicine to achieve better treatment results.